Clinical predictors and outcomes of consistent bronchodilator response in the childhood asthma management program

Sunita Sharma1, Augusto A Litonjua, Kelan G Tantisira

  • 1Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. ssharma4@partners.org

Insights

Children with consistent bronchodilator response (BDR) to asthma medications over time often have poorer outcomes. Predictors include lower lung function and higher IgE levels, indicating a need for closer monitoring.

Area of Science:

  • Pediatric Pulmonology
  • Asthma Phenotyping
  • Clinical Outcomes Research

Background:

  • Bronchodilator response (BDR) to beta(2)-agonists in asthma is variable.
  • The long-term significance of a consistent BDR is not well understood.

Purpose of the Study:

  • To identify baseline clinical predictors of a consistent BDR over 4 years in children with mild-to-moderate persistent asthma.
  • To determine the clinical outcomes associated with a consistent BDR phenotype.

Main Methods:

  • Analysis of 1041 children from the Childhood Asthma Management Program.
  • Defined consistent BDR as a >=12% and >=200 mL FEV(1) increase after beta(2)-agonist at yearly visits.
  • Compared clinical outcomes between children with and without consistent BDR.

Main Results:

  • Identified 52 children with consistent BDRs over 4 years.
  • Consistent BDR associated with lower baseline FEV(1), higher IgE, and no inhaled corticosteroid use.
  • Consistent BDR linked to increased hospital visits, prednisone use, nocturnal awakenings, and missed school days.

Conclusions:

  • Identified key predictors for a consistent bronchodilator response phenotype in pediatric asthma.
  • Demonstrated that a consistent BDR is associated with significantly worse asthma-related clinical outcomes.
Abstract

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...